Location: Kai Tak, Hong Kong
CIK: 0001782539 · Show all filings
Period: Q2 2026 (← Previous)
Filing Date: Aug 13, 2026
Total Value: $131M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ASND | ASCENDIS PHARMA A/S | 13,600 | $3.627M | 2.8% | $266.72 | — | ORD SHS | K08588103 |
| CHYM | CHIME FINL INC | 21,075 | $432K | 0.3% | $20.48 | — | COM SHS CL A | 16935C109 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| HELP | CYBIN INC | 987,222 (+114.6%) | $6.526M (+195.5%) | 5.0% | $6.53 | — | COM NEW | 23256X407 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ASND | ASCENDIS PHARMA A/S | 13,600 | $3.111M | 2.4% | $151.17 | — | — | 04351P101 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| OCS | OCULIS HOLDING AG | 300,565 (-14.3%) | $4.169M (-55.3%) | 3.2% | $11.25 | — | ORDINARY SHARES | H5870P102 |
| BOLT | BOLT BIOTHERAPEUTICS INC | 5,000 (-82.9%) | $19,250 (-83.7%) | 0.0% | $6.62 | — | COM NEW | 097702203 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MPLT | MAPLIGHT THERAPEUTICS INC | 971,253 | $34.81M | 26.5% | $16.75 | — | COM | 56565P103 |
| EVMN | EVOMMUNE INC | 1,441,032 | $19.15M | 14.6% | $18.78 | — | COM SHS | 30054Y107 |
| LBRX | LB PHARMACEUTICALS INC | 630,657 | $20.47M | 15.6% | $19.28 | — | COM SHS | 50180M108 |
| RVMD | REVOLUTION MEDICINES INC | 19,253 | $3.606M | 2.7% | $42.57 | — | COM | 76155X100 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 49,120 | $5.454M | 4.1% | $27.85 | — | COM | 76243J105 |
| INCY | INCYTE CORP | 53,742 | $6.092M | 4.6% | $63.22 | — | COM | 45337C102 |
| KYMR | KYMERA THERAPEUTICS INC | 30,875 | $3.54M | 2.7% | $41.86 | — | COM | 501575104 |
| PCOR | PROCORE TECHNOLOGIES INC | 53,299 | $2.165M | 1.6% | $73.96 | — | COM | 74275K108 |
| ARGX | ARGENX SE | 2,800 | $2.598M | 2.0% | $584.22 | — | SPONSORED ADR | 04016X101 |
| INSM | INSMED INC | 6,580 | $702K | 0.5% | $159.03 | — | COM PAR $.01 | 457669307 |
| RXRX | RECURSION PHARMACEUTICALS IN | 595,287 | $2.185M | 1.7% | $6.72 | — | CL A | 75629V104 |
| ACAD | ACADIA PHARMACEUTICALS INC | 102,984 | $2.605M | 2.0% | $23.42 | — | COM | 004225108 |
| CELC | CELCUITY INC | 28,300 | $2.961M | 2.3% | $107.47 | — | COM | 15102K100 |
| TRDA | ENTRADA THERAPEUTICS INC | 49,082 | $361K | 0.3% | $9.39 | — | COM | 29384C108 |
| HRMY | HARMONY BIOSCIENCES HLDGS IN | 27,049 | $985K | 0.7% | $30.00 | — | COM | 413197104 |
| ETHA | ISHARES ETHEREUM TR | 50,549 | $601K | 0.5% | $31.51 | — | SHS | 46438R105 |
| ONC | BEONE MEDICINES LTD | 15,722 | $4.48M | 3.4% | $213.29 | — | SPONSORED ADS | 07725L102 |
| IBIT | ISHARES BITCOIN TRUST ETF | 15,968 | $532K | 0.4% | $65.00 | — | SHS BEN INT | 46438F101 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 5,672 | $3.046M | 2.3% | $247.63 | — | COM | 558868105 |
| RANI | RANI THERAPEUTICS HLDGS INC | 493,584 | $375K | 0.3% | $17.30 | — | COM CL A | 753018100 |